8-KEarnings & ResultsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Financial Results (Oct 6, 2011)

Filed October 6, 2011For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) announced a significant change in its financial reporting structure, effective for its third fiscal quarter of 2011. The company is establishing a new reporting segment, "Specialty Diagnostics," bringing the total number of reporting segments to three. This reorganization aims to provide investors with a more granular view of the company's performance across its diversified operations. The press release attached to this 8-K filing includes historical financial data presented under this new segment structure, allowing for a comparative analysis of past performance in line with future reporting. This change in segment reporting is important for investors to understand as it will affect how the company's financial results are presented moving forward. Analyzing performance by segment can offer deeper insights into the growth drivers and operational efficiencies within each distinct business unit. Investors should review the provided historical data to understand the historical contribution of the newly formed Specialty Diagnostics segment and how it impacts the overall company performance trends.

Key Highlights

  • 1Thermo Fisher Scientific is introducing a new financial reporting segment called Specialty Diagnostics, effective Q3 2011.
  • 2The company will now report financial performance across three segments instead of the previous two.
  • 3The change is designed to offer investors a clearer view of performance within distinct business areas.
  • 4Historical financial results reflecting the new segment structure are included in the accompanying press release.
  • 5This update impacts how TMO's financial performance will be analyzed and compared in future filings.
  • 6The press release, including historical data, is furnished, not filed, under Section 18 of the Exchange Act.

Frequently Asked Questions

Thermo Fisher Scientific is creating a new financial reporting segment called Specialty Diagnostics. This will result in the company reporting its financial performance across three segments, rather than the previous two, starting with the third fiscal quarter of 2011.

This change is important because it will allow investors to better understand and analyze the financial performance of distinct parts of Thermo Fisher Scientific's business. The new Specialty Diagnostics segment will provide more focused insights into that specific area of operations, potentially highlighting growth trends or challenges more effectively.

Historical financial results presented under the new three-segment structure are included in the press release dated October 6, 2011, which is attached as Exhibit 99.1 to this Form 8-K filing and incorporated by reference.

No, this 8-K filing primarily focuses on the change in financial reporting segments. It announces the creation of the Specialty Diagnostics segment and provides historical financial data under this new structure. No new operational results or guidance are detailed beyond this reporting change.